Patents by Inventor Eric ROY
Eric ROY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20130052190Abstract: The present invention provides a method for the treatment of allergic and inflammatory diseases or conditions by administering a compound of Formula (I). The invention provides a method of treatment that is particularly suited for patients with a high degree of airway eosinophilia in contrast to those with a lower degree of airway eosinophilia. The invention also provides a method of treatment that is particularly suited for patients with a high atopic status in contrast to those patients with a lower atopic status.Type: ApplicationFiled: February 22, 2012Publication date: February 28, 2013Applicant: Oxagen LimitedInventors: Lisa Pearce Collins, Colin Michael Perkins, Michael Hunter, Eric Roy Pettipher
-
Publication number: 20120178515Abstract: There is an interactive video game having a lotterized aspect incorporated therein. In addition to the traditional interactive video game, instant and future win opportunities are presented to the player throughout the game. The game and win opportunities are played with a plurality of virtual currencies, the virtual currencies comprising credits for purchasing virtual goods in the game play instance, tokens applicable within the game play instance for participating in the real world lottery, and gifts representative of virtual goods exchangeable between players.Type: ApplicationFiled: January 9, 2012Publication date: July 12, 2012Applicant: INTERPROVINCIAL LOTTERY CORPORATIONInventors: Cameron ADAMS, George RASSIAS, Eric ROY, Jason LAM, Ken SCHULZKE, Louis-Philippe LUSSIER, Serge ROY, Todd HEINTZ
-
Publication number: 20120178514Abstract: There is described herein an interactive game having both lotterized and skill-based wagering aspects embedded therein. A skill-based game is used to provide players with the challenge and entertainment value that they are accustomed to experiencing in popular mobile games, while adding the possibility of collecting real world winnings via lotteries and other forms of wagering.Type: ApplicationFiled: January 9, 2012Publication date: July 12, 2012Applicant: INTERPROVINCIAL LOTTERY CORPORATIONInventors: Ken SCHULZKE, Cameron ADAMS, Eric ROY, George RASSIAS, Jason LAM, Louis-Philippe LUSSIER, Serge ROY, Todd HEINTZ
-
Patent number: 8191321Abstract: The system provides an n-s rail bracket that both supports a plurality of solar panels structurally, provides view-guards to hide electrical components, and a water conduit to channel water shed from the solar panel to a desired collection point provided by the structure. As such, the system includes an n-s structural rail consisting of a bottom wall and two vertically extending sidewalls. An intermediate horizontal member extends between the two sidewalls at or near their midpoint to form a compartment between the intermediate horizontal member, a lower portion of the left sidewall, the bottom wall, and a lower portion of the right side wall. Also, the intermediate horizontal member cooperates with an upper portion of the left side wall and an upper portion of the right sidewall to form a U-shaped channel. Each distal end of the respective left and right side wall includes a T-shaped shoulder for supporting the solar module.Type: GrantFiled: June 10, 2010Date of Patent: June 5, 2012Inventors: Vncent Jack McClellan, Eric Roy Morrison, Ry Reuter Heller
-
Publication number: 20110302857Abstract: The system provides an n-s rail bracket that both supports a plurality of solar panels structurally, provides view-guards to hide electrical components, and a water conduit to channel water shed from the solar panel to a desired collection point provided by the structure. As such, the system includes an n-s structural rail consisting of a bottom wall and two vertically extending sidewalls. An intermediate horizontal member extends between the two sidewalls at or near their midpoint to form a compartment between the intermediate horizontal member, a lower portion of the left sidewall, the bottom wall, and a lower portion of the right side wall. Also, the intermediate horizontal member cooperates with an upper portion of the left side wall and an upper portion of the right sidewall to form a U-shaped channel. Each distal end of the respective left and right side wall includes a T-shaped shoulder for supporting the solar module.Type: ApplicationFiled: June 10, 2010Publication date: December 15, 2011Applicant: ENERGY DESIGN CO.Inventors: Vince McClellan, Eric Roy Morrison, Ry Reuter Heller
-
Publication number: 20110142855Abstract: Compounds of general formula (I) wherein W is chloro or fluoro; R1 is phenyl optionally substituted with one or more substituents, selected from halo, —CN, —C1-C6 alkyl, —SOR3, —SO2R3, —SO2N(R2)2, —N(R2)2, —NR2C(O)R3, —CO2R2, —CONR2R3, —NO2, —OR2, —SR2, —O(CH2)pOR2, or —O(CH2)pO(CH2)qOR2 wherein each R2 is independently hydrogen, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; each R3 is independently, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; p and q are each independently an integer from 1 to 3; and R4 is hydrogen, C1-C6 alkyl, C1-C6 alkyl substituted with aryl, aryl, (CH2)mOC(?O)C1-C6alkyl, ((CH2)mO)nCH2CH2X, (CH2)mN(R5)2 or CH((CH2)mO(C?O)R6)2; m is 1 or 2; n is 1-4; X is OR5 or N(R5)2; R5 is hydrogen or methyl; and R6 is C1-C18 alkyl; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.Type: ApplicationFiled: January 26, 2011Publication date: June 16, 2011Applicant: Oxagen LimitedInventors: Richard Edward Armer, Eric Roy Pettipher, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer
-
Publication number: 20110124683Abstract: The invention relates to compounds of general formula (I): wherein R1, R2, R3, R4 and R5 are as defined herein for the treatment of allergic conditions, wherein the treatment is by pulsed therapy which comprises a first period during which the compound is administered to the patient and a second period of at least seven days during which the compound is administered to the patient in a reduced amount. The invention also relates to compounds of general formula (I) for desensitizing the immune system of a subject to allergens, thus preventing or reducing the symptoms of allergic conditions such as allergic asthma, allergic rhinitis, or atopic dermatitis.Type: ApplicationFiled: May 13, 2010Publication date: May 26, 2011Applicant: Oxagen LimitedInventors: Michael George Hunter, Eric Roy Pettipher, Colin Michael Perkins, Mark Anthony Payton, Luzheng Xue
-
Publication number: 20110123547Abstract: Compounds of general formula (II) wherein W is chloro or fluoro; R1 is phenyl optionally substituted with one or more substituents, selected from halo, —CN, —C1-C6 alkyl, —SOR3, —SO2R3, —SO2N(R2)2, —N(R2)2, —NR2C(O)R3, —CO2R2, —CONR2R3, —NO2, —OR2, —SR2, —O(CH2)pOR2, or —O(CH2)pO(CH2)qOR2 wherein each R2 is independently hydrogen, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; each R3 is independently, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; p and q are each independently an integer from 1 to 3; and R4 is hydrogen, C1-C6 alkyl, C1-C6 alkyl substituted with aryl, aryl, (CH2)mOC(?O)C1-C6alkyl, ((CH2)mO)nCH2CH2X, (CH2)mN(R5)2 or CH((CH2)mO(C?O)R6)2; m is 1 or 2; n is 1-4; X is OR5 or N(R5)2; R5 is hydrogen or methyl; and R6 is C1-C18 alkyl; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.Type: ApplicationFiled: January 31, 2011Publication date: May 26, 2011Applicant: Oxagen LimitedInventors: Richard Edward Armer, Eric Roy Pettipher, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer
-
Patent number: 7919512Abstract: Compounds of general formula (II) wherein W is chloro or fluoro; R1 is phenyl optionally substituted with one or more substituents, selected from halo, —CN, —C1-C6 alkyl, —SOR3, —SO2R3, —SO2N(R2)2, —N(R2)2, —NR2C(O)R3, —CO2R2, —CONR2R3, —NO2, —OR2, —SR2, —O(CH2)pOR2, or —O(CH2)pO(CH2)qOR2 wherein each R2 is independently hydrogen, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; each R3 is independently, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; p and q are each independently an integer from 1 to 3; and R4 is hydrogen, C1-C6 alkyl, C1-C6 alkyl substituted with aryl, aryl, (CH2)mOC(?O)C1-C6alkyl, ((CH2)mO)nCH2CH2X, (CH2)mN(R5)2 or CH((CH2)mO(C?O)R6)2; m is 1 or 2; n is 1-4; X is OR5 or N(R5)2; R5 is hydrogen or methyl; and R6 is C1-C18 alkyl; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.Type: GrantFiled: July 1, 2010Date of Patent: April 5, 2011Assignee: Oxagen LimitedInventors: Richard Edward Armer, Eric Roy Pettipher, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer
-
Publication number: 20100266535Abstract: Compounds of general formula (II) wherein W is chloro or fluoro; R1 is phenyl optionally substituted with one or more substituents, selected from halo, —CN, —C1-C6 alkyl, —SOR3, —SO2R3, —SO2N(R2)2, —N(R2)2, —NR2C(O)R3, —CO2R2, —CONR2R3, —NO2, —OR2, —SR2, —O(CH2)pOR2, or —O(CH2)pO(CH2)qOR2 wherein each R2 is independently hydrogen, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; each R3 is independently, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; p and q are each independently an integer from 1 to 3; and R4 is hydrogen, C1-C6 alkyl, C1-C6 alkyl substituted with aryl, aryl, (CH2)mOC(?O)C1-C6alkyl, ((CH2)mO)nCH2CH2X, (CH2)mN(R5)2 or CH((CH2)mO(C?O)R6)2; m is 1 or 2; n is 1-4; X is OR5 or N(R5)2; R5 is hydrogen or methyl; and R6 is C1-C18 alkyl; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.Type: ApplicationFiled: July 1, 2010Publication date: October 21, 2010Applicant: Oxagen LimitedInventors: Richard Edward ARMER, Eric Roy Pettipher, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer
-
Patent number: 7750027Abstract: Compounds of general formula (I) wherein W is chloro or fluoro; R1 is phenyl optionally substituted with one or more substituents, selected from halo, —CN, —C1-C6 alkyl, —SOR3, —SO2R3, —SO2N(R2)2, —N(R2)2, —NR2C(O)R3, —CO2R2, —CONR2R3, —NO2, —OR2, —SR2, —O(CH2)pOR2, or —O(CH2)pO(CH2)qOR2 wherein each R2 is independently hydrogen, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; each R3 is independently, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; p and q are each independently an integer from 1 to 3; and R4 is hydrogen, C1-C6 alkyl, C1-C6 alkyl substituted with aryl, aryl, (CH2)mOC(?O)C1-C6alkyl, ((CH2)mO)nCH2CH2X, (CH2)mN(R5)2 or CH((CH2)mO(C?O)R6)2; m is 1 or 2; n is 1-4; X is OR5 or N(R5)2; R5 is hydrogen or methyl; and R6 is C1-C18 alkyl; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.Type: GrantFiled: November 24, 2009Date of Patent: July 6, 2010Assignee: Oxagen LimitedInventors: Richard Edward Armer, Eric Roy Pettipher, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer
-
Patent number: 7741484Abstract: A method for preparing a compound of formula I the method comprising treating a compound of formula d with an iodination reagent, to form the compound of formula I, wherein R1, R2 and R3 are as defined herein.Type: GrantFiled: August 25, 2006Date of Patent: June 22, 2010Assignee: Roche Palo Alto LLCInventors: Anton Constantinescu, Keena Lynn Green, Eric Roy Humphreys, Gary R. Lee, Patrick Finbar McGarry
-
Publication number: 20100063103Abstract: Compounds of general formula (I) wherein W is chloro or fluoro; R1 is phenyl optionally substituted with one or more substituents, selected from halo, —CN, —C1-C6 alkyl, —SOR3, —SO2R3, —SO2N(R2)2, —N(R2)2, —NR2C(O)R3, —CO2R2, —CONR2R3, —NO2, —OR2, —SR2, —O(CH2)pOR2, or —O(CH2)pO(CH2)qOR2 wherein each R2 is independently hydrogen, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; each R3 is independently, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; p and q are each independently an integer from 1 to 3; and R4 is hydrogen, C1-C6 alkyl, C1-C6 alkyl substituted with aryl, aryl, (CH2)mOC(?O)C1-C6alkyl, ((CH2)mO)nCH2CH2X, (CH2)mN(R5)2 or CH((CH2)mO(C?O)R6)2; m is 1 or 2; n is 1-4; X is OR5 or N(R5)2; R5 is hydrogen or methyl; and R6 is C1-C18 alkyl; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.Type: ApplicationFiled: November 24, 2009Publication date: March 11, 2010Applicant: Oxagen LimitedInventors: Richard Edward ARMER, Eric Roy Pettipher, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer
-
Patent number: 7617684Abstract: A can combustor includes a generally cylindrical housing having an interior, an axis, and a closed axial end. The closed axial end includes means for introducing fuel to the housing interior. A generally cylindrical combustor liner is disposed coaxially within the housing and configured to define with the housing respective radially outer passages for combustion air and for dilution air, and also respective radially inner volumes for a combustion zone and a dilution zone. The combustion zone is disposed axially adjacent the closed housing end, and the dilution zone is disposed axially distant the closed housing end. The can combustor also includes an impingement cooling sleeve coaxially disposed between the housing and the combustor liner and extending axially from the closed housing end for a substantial length of the combustion zone.Type: GrantFiled: November 13, 2007Date of Patent: November 17, 2009Assignee: Opra Technologies B.V.Inventor: Eric Roy Norster
-
Patent number: 7598399Abstract: A method comprising: hydrogenating an indole propionamide compound of formula h with vitride, to form an aminopropyl indole compound of formula i wherein m, Ar, R1 and R2 are as defined herein. The compounds prepared by the method of the invention are useful as monoamine reuptake inhibitors useful for treatment of CNS indications.Type: GrantFiled: November 29, 2006Date of Patent: October 6, 2009Assignee: Roche Palo Alto LLCInventors: Terrence Joseph Connolly, Robert P. Farrell, Eric Roy Humphreys, Stephen M. Lynch, Keshab Sarma
-
Publication number: 20090186923Abstract: Compounds of general formula (I) wherein W is chloro or fluoro; R1 is phenyl optionally substituted with one or more substituents selected from halo, —CN, —C1-C6 alkyl, —SOR3, —SO2R3, —SO2N(R2)2, —N(R2)2, —NR2C(O)R3, —CO2R2, —CONR2R3, —NO2, —OR2, —SR2, —O(CH2)pOR2, and —O(CH2)p—O—(CH2)qOR2 wherein each R2 is independently hydrogen, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; each R3 is independently, —C1-C6 alkyl, —C3-C8 cycloalkyl, aryl or heteroaryl; p and q are each independently an integer from 1 to 3; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.Type: ApplicationFiled: January 21, 2009Publication date: July 23, 2009Inventors: Richard Edward Armer, Eric Roy Pettipher, Mark Whittaker, Graham Michael Wynne, Julia Vile, Frank Schroer
-
Publication number: 20090120094Abstract: A can combustor includes a generally cylindrical housing having an interior, an axis, and a closed axial end. The closed axial end includes means for introducing fuel to the housing interior. A generally cylindrical combustor liner is disposed coaxially within the housing and configured to define with the housing respective radially outer passages for combustion air and for dilution air, and also respective radially inner volumes for a combustion zone and a dilution zone. The combustion zone is disposed axially adjacent the closed housing end, and the dilution zone is disposed axially distant the closed housing end. The can combustor also includes an impingement cooling sleeve coaxially disposed between the housing and the combustor liner and extending axially from the closed housing end for a substantial length of the combustion zone.Type: ApplicationFiled: November 13, 2007Publication date: May 14, 2009Inventor: Eric Roy Norster
-
Publication number: 20090023788Abstract: The present invention provides indole derivatives that antagonize prostaglandin D2, and that can be used to treat inflammatory diseases mediated by prostaglandin D2.Type: ApplicationFiled: September 17, 2008Publication date: January 22, 2009Applicant: Oxagen LimitedInventors: David Middlemiss, Mark Richard Ashton, Edward Andrew Boyd, Frederick Arthur Brookfield, Eric Roy Pettipher, Michael George Hunter, Mark Whittaker, Chris Palmer
-
Publication number: 20040121969Abstract: The present invention relates to nucleosides of formula I wherein R1, R2 and R3 are as defined herein that modulateTh1 and Th2 immune activity, methods of using compounds according to formula I, alone or in combination therapy, for treatment of a bacterial or a viral infection, a parasite infestation, a cancer or tumor or an autoimmune disease and compositions containing prodrugs of the nucleoside of formula Ia.Type: ApplicationFiled: December 9, 2003Publication date: June 24, 2004Applicant: Roche Palo Alto LLCInventors: Robert Than Hendricks, Eric Roy Humphreys, Joseph Armstrong Martin, Anthony Prince, Keshab Sarma
-
Patent number: 6532726Abstract: A gas-turbine engine combustion system has a combustor with a burner head having both pilot gas and pilot liquid-fuel injection arrangements, the pilot gas arrangement comprising an annular gallery communicating with a downstream face of the head and a deflecting arrangement adjacent the gallery for directing the pilot gas-fuel towards a longitudinal axis of the combustor and over a central part of the downstream face. The combustion system is designed so that, during both gas- and liquid-fuel operations, the flame front face is located close to the burner head and, during liquid-fuel operation, air is forced across the downstream face to cool the head. Advantageously, the cooling air is made to replace the pilot gas-fuel in the annular gallery, so that it is deflected, like the gas-fuel, and contacts the central part of the downstream face. The burner head also features main gas and liquid-fuel injection arrangements, these communicating with one or more passageways in a radial swirler attached to the head.Type: GrantFiled: January 29, 1999Date of Patent: March 18, 2003Assignee: Alstom Gas Turbines, Ltd.Inventors: Eric Roy Norster, Simon DePietro, Mahmoud Kowkabi, Hoger Gunter Heinrich Hesse